The annual meeting of the American Society for Radiation Oncology was held from Sept. 27 to Oct. 1 in San Francisco, drawing ...

TTFields treatment following stereotactic radiosurgery prolonged the time to intracranial progression for patients with brain metastases from NSCLC.

Ten-year STARS trial data show stereotactic ablative radiotherapy provides survival outcomes comparable to surgery in ...

For patients with non-small cell lung cancer (NSCLC), stereotactic ablative radiotherapy (SABR) offers long-term survival ...

GenesisCare UK appoints Dr Peter Dickinson to lead its Elekta Unity MR Linac programme Having recently been granted planning approval for their fifteenth specialist cancer care centre, GenesisCare UK ...

Precision-targeted radiation is proving a match for surgery in early-stage lung cancer, offering patients similar long-term ...

The radiotherapy technology controlled localised disease while triggering no adverse events (AEs) rated Grade 2 or higher.

A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC).

A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to ...

Novocure (NASDAQ: NVCR) announced that final results from the Phase 3 METIS trial of Tumor Treating Fields (TTFields) therapy for brain metastases from non-small cell lung cancer (NSCLC) will be ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. This open-label, randomised ...